|
1
|
Woodcock T and Morganti-Kossmann MC: The
role of markers of inflammation in traumatic brain injury. Front
Neurol. 4:182013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith DH, Johnson VE and Stewart W:
Chronic neuropathologies of single and repetitive TBI: Substrates
of dementia? Nat Rev Neurol. 9:211–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Russo MV and McGavern DB: Inflammatory
neuroprotection following traumatic brain injury. Science.
353:783–785. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bye N, Habgood MD, Callaway JK, Malakooti
N, Potter A, Kossmann T and Morganti-Kossmann MC: Transient
neuroprotection by minocycline following traumatic brain injury is
associated with attenuated microglial activation but no changes in
cell apoptosis or neutrophil infiltration. Exp Neurol. 204:220–233.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clark RS, Schiding JK, Kaczorowski SL,
Marion DW and Kochanek PM: Neutrophil accumulation after traumatic
brain injury in rats: Comparison of weight drop and controlled
cortical impact models. J Neurotrauma. 11:499–506. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dinkel K, Dhabhar FS and Sapolsky RM:
Neurotoxic effects of polymorphonuclear granulocytes on hippocampal
primary cultures. Proc Natl Acad Sci USA. 101:331–336. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nguyen HX, O'Barr TJ and Anderson AJ:
Polymorphonuclear leukocytes promote neurotoxicity through release
of matrix metalloproteinases, reactive oxygen species, and
TNF-alpha. J Neurochem. 102:900–912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bergold PJ: Treatment of traumatic brain
injury with anti-inflammatory drugs. Exp Neurol. 275:367–380. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martin E, Ramsay G, Mantz J and Sum-Ping
ST: The role of the alpha2-adrenoceptor agonist dexmedetomidine in
postsurgical sedation in the intensive care unit. J Intensive Care
Med. 18:29–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sukegawa S, Higuchi H, Inoue M, Nagatsuka
H, Maeda S and Miyawaki T: Locally injected dexmedetomidine
inhibits carrageenin-induced inflammatory responses in the injected
region. Anesth Analg. 118:473–480. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taniguchi T, Kidani Y, Kanakura H,
Takemoto Y and Yamamoto K: Effects of dexmedetomidine on mortality
rate and inflammatory responses to endotoxin-induced shock in rats.
Crit Care Med. 32:1322–1326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yagmurdur H, Ozcan N, Dokumaci F, Kilinc
K, Yilmaz F and Basar H: Dexmedetomidine reduces the
ischemia-reperfusion injury markers during upper extremity surgery
with tourniquet. J Hand Surg Am. 33:941–947. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawasaki T, Kawasaki C, Ueki M, Hamada K,
Habe K and Sata T: Dexmedetomidine suppresses proinflammatory
mediator production in human whole blood in vitro. J Trauma Acute
Care Surg. 74:1370–1375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim Y, Kang SH, Hong TH, Cho ML, Han HJ,
Kwon SJ and Lee J: Effects of dexmedetomidine on the ratio of T
helper 1 to T helper 2 cytokines in patients undergoing
laparoscopic cholecystectomy. J Clin Anesth. 26:281–285. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Naguib AN, Tobias JD, Hall MW, Cismowski
MJ, Miao Y, Barry N, Preston T, Galantowicz M and Hoffman TM: The
role of different anesthetic techniques in altering the stress
response during cardiac surgery in children: A prospective,
double-blinded, and randomized study. Pediatr Crit Care Med.
14:481–490. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ueki M, Kawasaki T, Habe K, Hamada K,
Kawasaki C and Sata T: The effects of dexmedetomidine on
inflammatory mediators after cardiopulmonary bypass. Anaesthesia.
69:693–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia R, Yin H, Xia ZY, Mao QJ, Chen GD and
Xu W: Effect of intravenous infusion of dexmedetomidine combined
with inhalation of isoflurane on arterial oxygenation and
intrapulmonary shunt during single-lung ventilation. Cell Biochem
Biophys. 67:1547–1550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xin J, Zhang YB, Zhou L, Liu F, Zhou X,
Liu B and Li Q: Effect of dexmedetomidine infusion for intravenous
patient-controlled analgesia on the quality of recovery after
laparotomy surgery. Oncotarget. 8:100371–100383. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aho M, Erkola O, Kallio A, Scheinin H and
Korttila K: Dexmedetomidine infusion for maintenance of anesthesia
in patients undergoing abdominal hysterectomy. Anesth Analg.
75:940–946. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Talke P, Richardson CA, Scheinin M and
Fisher DM: Postoperative pharmacokinetics and sympatholytic effects
of dexmedetomidine. Anesth Analg. 85:1136–1142. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Taittonen MT, Kirrvelä OA, Aantaa R and
Kanto JH: Effect of clonidine and dexmedetomidine premedication on
perioperative oxygen consumption and haemodynamic state. Br J
Anaesth. 78:400–406. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bekker A, Gold M, Ahmed R, Kim J, Rockman
C, Jacobovitz G, Riles T and Fisch G: Dexmedetomidine does not
increase the incidence of intracarotid shunting in patients
undergoing awake carotid endarterectomy. Anesth Analg. 103:955–958.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bekker AY, Basile J, Gold M, Riles T,
Adelman M, Cuff G, Mathew JP and Goldberg JD: Dexmedetomidine for
awake carotid endarterectomy: Efficacy, hemodynamic profile, and
side effects. J Neurosurg Anesthesiol. 16:126–135. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaygusuz K, Gokce G, Gursoy S, Ayan S,
Mimaroglu C and Gultekin Y: A comparison of sedation with
dexmedetomidine or propofol during shockwave lithotripsy: A
randomized controlled trial. Anesth Analg. 106:114–119, table of
contents. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Naaz S and Ozair E: Dexmedetomidine in
current anaesthesia practice-a review. J Clin Diagn Res.
8:GE01–GE04. 2014.PubMed/NCBI
|
|
26
|
Munro HM, Tirotta CF, Felix DE, Lagueruela
RG, Madril DR, Zahn EM and Nykanen DG: Initial experience with
dexmedetomidine for diagnostic and interventional cardiac
catheterization in children. Paediatr Anaesth. 17:109–112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tasdogan M, Memis D, Sut N and Yuksel M:
Results of a pilot study on the effects of propofol and
dexmedetomidine on inflammatory responses and intraabdominal
pressure in severe sepsis. J Clin Anesth. 21:394–400. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Memiş D, Hekimoğlu S, Vatan I, Yandim T,
Yüksel M and Süt N: Effects of midazolam and dexmedetomidine on
inflammatory responses and gastric intramucosal pH to sepsis, in
critically ill patients. Br J Anaesth. 98:550–552. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Wang Z, Wang Y, Zhou G and Li H:
The effect of dexmedetomidine on inflammatory response of septic
rats. BMC Anesthesiol. 15:682015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Romine J, Gao X and Chen J: Controlled
cortical impact model for traumatic brain injury. J Vis Exp.
e517812014.PubMed/NCBI
|
|
31
|
Inada T, Sumi C, Hirota K, Shingu K,
Okamoto A, Matsuo Y and Kamibayashi T: Mitigation of inflammation
using the intravenous anesthetic dexmedetomidine in the mouse air
pouch model. Immunopharm Immunot. 39:225–232. 2017. View Article : Google Scholar
|
|
32
|
Cagle LA, Franzi LM, Epstein SE, Kass PH,
Last JA and Kenyon NJ: Injectable anesthesia for mice: Combined
effects of dexmedetomidine, tiletamine-zolazepam, and butorphanol.
Anesthesiol Res Pract. 2017:91610402017.PubMed/NCBI
|
|
33
|
Pan W, Hua X, Wang Y, Guo R, Chen J and Mo
L: Dose response of dexmedetomidine-induced resistance to hypoxia
in mice. Mol Med Rep. 14:3237–3242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weischenfeldt J and Porse B: Bone
marrow-derived macrophages (BMM): Isolation and applications. CSH
Protoc 2008: pdb prot5080. 2008.
|
|
35
|
Swirski FK, Nahrendorf M, Etzrodt M,
Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler
RH, Chudnovskiy A, Waterman P, Aikawa E, et al: Identification of
splenic reservoir monocytes and their deployment to inflammatory
sites. Science. 325:612–616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maas AI, Stocchetti N and Bullock R:
Moderate and severe traumatic brain injury in adults. Lancet
Neurol. 7:728–741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Langlois JA, Rutland-Brown W and Wald MM:
The epidemiology and impact of traumatic brain injury: A brief
overview. J Head Trauma Rehabil. 21:375–378. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Behrens V, Dudaryk R, Nedeff N, Tobin JM
and Varon AJ: The ryder cognitive aid checklist for trauma
anesthesia. Anesth Analg. 122:1484–1487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tobin JM, Grabinsky A, McCunn M, Pittet
JF, Smith CE, Murray MJ and Varon AJ: A checklist for trauma and
emergency anesthesia. Anesth Analg. 117:1178–1184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brough D, Tyrrell PJ and Allan SM:
Regulation of interleukin-1 in acute brain injury. Trends Pharmacol
Sci. 32:617–622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fan L, Young PR, Barone FC, Feuerstein GZ,
Smith DH and McIntosh TK: Experimental brain injury induces
expression of interleukin-1 beta mRNA in the rat brain. Brain Res
Mol Brain Res. 30:125–130. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Singhal A, Baker AJ, Hare GMT, Reinders
FX, Schlichter LC and Moulton RJ: Association between cerebrospinal
fluid interleukin-6 concentrations and outcome after severe human
traumatic brain injury. J Neurotrauma. 19:929–937. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Frugier T, Morganti-Kossmann MC, O'Reilly
D and McLean CA: In situ detection of inflammatory mediators in
post mortem human brain tissue after traumatic injury. J
Neurotrauma. 27:497–507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Scherbel U, Raghupathi R, Nakamura M,
Saatman KE, Trojanowski JQ, Neugebauer E, Marino MW and McIntosh
TK: Differential acute and chronic responses of tumor necrosis
factor-deficient mice to experimental brain injury. Proc Natl Acad
Sci USA. 96:8721–8726. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stahel PF, Shohami E, Younis FM, Kariya K,
Otto VI, Lenzlinger PM, Grosjean MB, Eugster HP, Trentz O, Kossmann
T, et al: Experimental closed head injury: Analysis of neurological
outcome, blood-brain barrier dysfunction, intracranial neutrophil
infiltration, and neuronal cell death in mice deficient in genes
for pro-inflammatory cytokines. J Cereb Blood Flow Metab.
20:369–380. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Romano M, Sironi M, Toniatti C,
Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van
Hinsbergh V, Sozzani S, et al: Role of IL-6 and its soluble
receptor in induction of chemokines and leukocyte recruitment.
Immunity. 6:315–325. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Banks WA: Blood-brain barrier transport of
cytokines: A mechanism for neuropathology. Curr Pharm Des.
11:973–984. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Morganti-Kossmann MC, Kossmann T and Wahl
SM: Cytokines and neuropathology. Trends Pharmacol Sci. 13:286–291.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kushi H, Saito T, Makino K and Hayashi N:
IL-8 is a key mediator of neuroinflammation after traumatic brain
injury. Crit Care Med. 30:A822002. View Article : Google Scholar
|
|
50
|
Dimitrijevic OB, Stamatovic SM, Keep RF
and Andjelkovic AV: Absence of the chemokine receptor CCR2 protects
against cerebral Ischemia/reperfusion injury in mice. Stroke.
38:1345–1353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Izikson L, Klein RS, Charo IF, Weiner HL
and Luster AD: Resistance to experimental autoimmune
encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.
J Exp Med. 192:1075–1080. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Semple BD, Bye N, Rancan M, Ziebell JM and
Morganti-Kossmann MC: Role of CCL2 (MCP-1) in traumatic brain
injury (TBI): Evidence from severe TBI patients and CCL2-/- mice. J
Cerebr Blood Flow Metab. 30:769–782. 2010. View Article : Google Scholar
|
|
53
|
Shechter R, London A, Varol C, Raposo C,
Cusimano M, Yovel G, Rolls A, Mack M, Pluchino S, Martino G, et al:
Infiltrating blood-derived macrophages are vital cells playing an
anti-inflammatory role in recovery from spinal cord injury in mice.
PLoS Med. 6:e10001132009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Weber MS, Prod'homme T, Youssef S, Dunn
SE, Rundle CD, Lee L, Patarroyo JC, Stüve O, Sobel RA, Steinman L
and Zamvil SS: Type II monocytes modulate T cell-mediated central
nervous system autoimmune disease. Nat Med. 13:935–943. 2007.
View Article : Google Scholar : PubMed/NCBI
|
